Viewing Study NCT00670592


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-02-03 @ 10:22 PM
Study NCT ID: NCT00670592
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2008-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
None Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCD122 View
None CD40 View
None NHL View
None HL View